Ophthalmic Features and Prevalence of Systemic Disorders in Participants in the QRK07 NAION Treatment Trial
Creator
Neil Miller; Nathalie Jette; Rachelle Morgenstern; Parul Agarwal; Leonard Levin; Mark Kupersmith
Affiliation
(NM) Wilmer Eye Institute, Johns Hopkins University School of Medicine; (NJ) (RM) (PA) Mt Sinai; (LL) McGill University; (MK)Departments of Neurology and Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY
Subject
Optic Neuropathy; Vascular Disorders
Description
The QRK207 study was the first multi-country treatment trial for patients with acute nonarteritic anterior ischemic optic neuropathy (NAION). We assessed ophthalmic and systemic factors associated with an increased risk of NAION and examined if they varied across countries.
Date
2023-03
References
None provided.
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
2023 North American Neuro-Ophthalmology Society Annual Meeting